Kura腫瘤學 KURA 深 滬
等待開盤 08-13 09:30:00 美东时间
6.20
+0.660
+11.91%
華盛通- 最 高6.218
- 今 開5.60
- 成交量 173.36万股
- 最 低 5.52
- 昨 收 5.54
- 總市值 5.37亿
- 52周最高 21.569
- 市盈率 靜 --
- 換手率 2.00%
- 52周最低 5.41
- 委 比 -88.24%
- 總股本 8657.47万
- 歷史最高 43.00
- 量 比 0.97
- 振 幅 12.60%
- 歷史最低 2.50
- 每 手 1
- 風險率 4.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多JMP Securities Maintains Market Outperform on Kura Oncology, Lowers Price Target to $24
JMP Securities analyst Reni J. Benjamin maintains Kura Oncology (NASDAQ:KURA) with a Market Outperform and lowers the price target from $28 to $24.
08-11 20:16
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
SAKURA Internet Inc. (3778) Receives a Hold from Nomura
Nomura analyst Daisaku Masuno maintained a Hold rating on SAKURA Internet Inc. ...
08-05 22:06
Kura Oncology to Report Second Quarter 2025 Financial Results
Kura Oncology, a clinical-stage biopharmaceutical company focused on precision cancer medicines, will report its second quarter 2025 financial results on August 7, 2025, followed by a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT. Ziftomenib, its lead candidate, has received FDA Breakthrough Therapy Designation for relapsed or refractory NPM1-mutant AML and is under review with a PDUFA date of November 30, 2025. The company is also a...
07-31 11:30
SAKURA Internet Revises Earnings Forecast Amid GPU Sales Decline
An announcement from SAKURA Internet Inc. ( ($JP:3778) ) is now available. SAKU...
07-29 07:52
Kyverna Therapeutics appoints Marc Grasso as CFO
Kyverna Therapeutics (NASDAQ:KYTX) announced on Monday the appointment of Marc Grasso as its chief financial officer (CFO), effective today. Most recently, Grasso served as CFO of Alector, a clinical...
06-30 21:32
Cantor Fitzgerald Reiterates Overweight on Kura Oncologyto Overweight
Cantor Fitzgerald analyst Li Watsek reiterates Kura Oncology (NASDAQ:KURA) from Overweight to Overweight.
06-26 21:36
Kura Sushi USA to Announce Fiscal Third Quarter 2025 Financial Results on July 8, 2025
Kura Sushi USA will host a conference call on July 8, 2025, to discuss their fiscal third quarter 2025 financial results. The call, hosted by Hajime “Jimmy” Uba, Jeff Uttz, and Benjamin Porten, will begin at 5:00 p.m. ET. Interested parties can join by phone at 201-689-8471 or via webcast at www.kurasushi.com. A replay will be available shortly after the call. Kura Sushi has 77 locations across the U.S. and offers a revolving sushi service. For i...
06-24 13:00
美股大行评级 | 潜在涨幅378.93%！aTyr Pharma获富国银行升目标价至25美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1143101010774646784.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 富国银行：维持aTyr Pharma(ATYR)"超配"评级，目标价从17美元升至25美元</p> <p>• 摩根大通：维持Array Technologies(ARRY)"超配"评级，目标价从12美元升至13美元</p>
06-21 08:35
